Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6873 - 6880 of 12092 results

ITC Denies Suspension or Temporary Rescission of Remedial Orders After PTAB Invalidates Patents at Issue
July 28, 2017| Blog| Viewpoint

2017 Nantucket Impact Capitalism Summit Highlights Importance of Impact Investing
July 27, 2017| Blog| Viewpoint

2nd Circ. Offers Insight On 'Class Arbitration' Questions
July 27, 2017| News

Vacation Float: Managing (and Recouping) Unearned Vacation Time
July 26, 2017| Blog| Viewpoint

Retailers: Review Those Checkout Practices - Again
July 26, 2017| Blog| Viewpoint

Federal Circuit Thoroughly Reverses District Court Findings of Velcade® Patent Obviousness
July 26, 2017| Blog| Viewpoint

Witnesses at Congressional Hearing on 340B Urge Congress To Give HRSA Broader Regulatory Authority
July 25, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
